A Genomewide Exploration Suggests a New Candidate Gene at Chromosome 11q23 as the Major Determinant of Plasma Homocysteine Levels: Results from the GAIT Project
- 1 June 2005
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 76 (6), 925-933
- https://doi.org/10.1086/430409
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Genome scan of venous thrombosis in a pedigree with protein C deficiencyJournal of Thrombosis and Haemostasis, 2004
- Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2)Genetic Epidemiology, 2003
- A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibilityBlood, 2003
- Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriographyHuman Genetics, 2002
- A Quantitative-Trait Locus in the Human Factor XII Gene Influences Both Plasma Factor XII Levels and Susceptibility to Thrombotic DiseaseAmerican Journal of Human Genetics, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Merlin—rapid analysis of dense genetic maps using sparse gene flow treesNature Genetics, 2001
- Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT StudyAmerican Journal of Human Genetics, 2000
- Human nicotinamide N-methyltransferase pharmacogeneticsPharmacogenetics, 1999
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995